Ekachai Medical Care PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	1,240	1,307	1,209	1,049	1,146
Other Revenue	18.32	-	-	-	-
Revenue	1,258	1,307	1,209	1,049	1,146
Revenue Growth (YoY)	-3.74%	8.13%	15.27%	-8.54%	77.52%
Cost of Revenue	721.92	718.76	669.22	609	602.79
Gross Profit	536.03	588.13	539.39	439.51	543.57
Selling, General & Admin	220.77	281.17	223.9	197.33	173.05
Operating Expenses	220.77	281.17	223.9	197.33	173.05
Operating Income	315.26	306.95	315.49	242.18	370.52
Interest Expense	-1.68	-1.91	-1.65	-1.62	-1.81
Interest & Investment Income	-	35.62	26.24	17.68	1.37
Earnings From Equity Investments	0	-1.21	-0.07	-	-
Other Non Operating Income (Expenses)	24.26	14.09	13.29	17.55	10.29
EBT Excluding Unusual Items	337.84	353.54	353.3	275.79	380.37
Gain (Loss) on Sale of Investments	-	-	19.5	409.96	44.38
Pretax Income	337.84	353.54	372.8	685.75	424.76
Income Tax Expense	66.4	63.21	70.58	134.86	84.25
Earnings From Continuing Operations	271.44	290.34	302.22	550.89	340.51
Minority Interest in Earnings	-9.14	-10.28	-4.96	0.44	4.32
Net Income	262.3	280.06	297.26	551.32	344.83
Net Income to Common	262.3	280.06	297.26	551.32	344.83
Net Income Growth	-6.34%	-5.79%	-46.08%	59.88%	378.24%
Shares Outstanding (Basic)	816	767	715	677	653
Shares Outstanding (Diluted)	816	767	752	710	657
Shares Change (YoY)	6.38%	2.04%	5.83%	8.22%	0.40%
EPS (Basic)	0.32	0.37	0.42	0.81	0.53
EPS (Diluted)	0.32	0.36	0.40	0.78	0.53
EPS Growth	-11.95%	-7.66%	-49.06%	47.75%	376.28%
Free Cash Flow	-73.69	62.61	280.81	235.31	289.36
Free Cash Flow Per Share	-0.09	0.08	0.37	0.33	0.44
Dividend Per Share	-	0.550	0.293	0.305	0.229
Dividend Growth	-	87.91%	-3.91%	33.13%	127.21%
Gross Margin	42.61%	45.00%	44.63%	41.92%	47.42%
Operating Margin	25.06%	23.49%	26.10%	23.10%	32.32%
Profit Margin	20.85%	21.43%	24.59%	52.58%	30.08%
Free Cash Flow Margin	-5.86%	4.79%	23.23%	22.44%	25.24%
EBITDA	400.07	386.08	394.01	311.92	438.54
EBITDA Margin	31.80%	29.54%	32.60%	29.75%	38.26%
D&A For EBITDA	84.81	79.13	78.52	69.74	68.03
EBIT	315.26	306.95	315.49	242.18	370.52
EBIT Margin	25.06%	23.49%	26.10%	23.10%	32.32%
Effective Tax Rate	19.65%	17.88%	18.93%	19.67%	19.83%
Revenue as Reported	1,258	1,329	1,258	1,491	1,201

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.